DexCom Inc - DXCM Net earnings per share for the last four quarters

DexCom Inc (DXCM) - corporate logo

The fierce battle for leadership in sensor technologies requires colossal R&D expenditures, which impacts the 12-month YoY EPS trend, where the current mark is 40.60. Stability provides DexCom, Inc. (DXCM) immunity to trade wars, while a strong talent pool of equity-motivated bioengineers guarantees the development of innovative gadgets for diabetics.

dexcom.com (DXCM) Net earnings per share for the last 12 months: for the period 02/11/2024 - 11/12/2026

Dexcom Corp - analytical breakdowns and key metrics (DXCM)

- stock price and consensus target price:
Price dexcom.com|DXCM - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization DexCom Inc|DXCM - Enterprise Value
- book value of equity indicators:
Accounting Value per Share Dexcom|DXCM - Company Net Assets|Market Value to Book Value dexcom.com|DXCM - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio DexCom, Inc.|DXCM - Long-Term Debt to Capital|Current Liabilities to Capital Dexcom CGM|DXCM - Company Aggregate Debts|Debt to Book Value Ratio DexCom Inc|DXCM - Company Long-Term Debts|Short-Term Debt Volume Dexcom|Quick Liquidity Indicator dexcom.com
- earnings and market multiples details:
DXCM - Net Profit|Projected Future Earnings DexCom, Inc.|DXCM - Price to Earnings Ratio|Future Price to Earnings DexCom Inc|DXCM - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation DexCom Inc|DXCM - Operating profit EBITDA|Net earnings per one share for the last twelve months Dexcom|DXCM - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year dexcom.com|DXCM - Net earnings per share growth this year|Earnings growth forecast for next year DexCom, Inc.
Fundamental company valuation:dexcom.com, DXCM
Manufactured product of Dexcom

Year-over-year (YoY) EPS growth (TTM) measures the rate of change in net income per share over a rolling twelve-month period. By analyzing the annual dynamics of the EPS TTM figure, an investor assesses the efficiency of profit generation relative to past results. This metric is calculated as the percentage deviation of the current earnings value from the same window of the previous year. For DexCom, Inc. (DXCM), this indicator is critical when assessing the impact of price wars and new weight-loss drugs on business profitability.

Competitor analysis for DexCom, Inc.

penumbrainc.com - Earnings per share for the last four quarters|NOVT: Net earnings per share (EPS TTM)|HAE - Net earnings per share for the last four quarters|INSP (Inspire Sleep) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Procept (PRCT)|Net earnings per share for the last 12 months CNMD (CONMED Corporation)|PLSE (pulsebiosciences.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months InMode INMD|PMI - Net earnings per share for the last 12 months|Surmodics Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Senseonics Holdings|NPCE: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months TCMD|SNWV (SANUWAVE) - Net earnings per share (EPS TTM)|Outset Medical Inc (OM) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) ELMD|Net earnings per share for the last 12 months LENSAR Inc LNSR|Net earnings per share (EPS TTM) RCEL (AVITA Medical, Inc.)|Net earnings per share (EPS TTM) Profound Medical Corp PROF|BDMD - Earnings per share for the last twelve months|EDAP: Earnings per share for the last twelve months|APYX (apyxmedical.com) - Net earnings per share for the last 12 months|IceCure Medical - Earnings per share for the trailing year|LUNG (Pulmonx Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months TELA Bio Corp TELA|Earnings per share for the last twelve months Cytosorbents (CTSO)|Sensus Healthcare Inc (SRTS) - Net earnings per share for the trailing year|Zynex Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) electroCore Inc ECOR|Vicarious Surgical Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Inspira Technologies Oxy IINN|SeaStar Medical (ICU) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months IRIX (IRIDEX)|Earnings per share for the last twelve months Intelligent Bio Solutions Inc|Net earnings per share for the last 12 months AINostix (XAIR)|Net earnings per share (EPS TTM) PFSA|SSKN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months GlucoTrack GCTK|NAOV: Earnings per share for the last 12 months|VERO: Net earnings per share for the last 12 months|Nuwellis Corp - Earnings per share for the last four quarters|AEMD: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months ASXC|AVGR (Avinger) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months BioSig Technologies, Inc BSGM|Net earnings per share for the last 12 months CUTR (Cutera, Inc)|Know Labs Corporation - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NARI (Inari Medical, Inc.)|NVRO - Net earnings per share for the last 12 months|RSLS - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Silk Road Medical, Inc.